Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose this investigation is to more thoroughly investigate the effects of ranolazine on
arrhythmias and microvolt t-wave alternans in patients who have an automatic implantable
cardioverter defibrillator (AICD) implanted either prophylactically to prevent sudden cardiac
death, as well as in patients who may have had a clinically significant arrhythmic event
prompting the insertion of the automatic implantable cardioverter defibrillator. It is
anticipated this study will provide valuable new insight into the potential use of ranolazine
to treat arrhythmias in higher risk patients.
Phase:
Phase 3
Details
Lead Sponsor:
Aspirus Heart and Vascular Institute-Research and Education